[Comment] Chronic liver disease: scavenger hunt for novel therapies

Chronic liver disease (CLD) is a major cause of global mortality and morbidity. However, therapeutic breakthroughs have been made in the field of viral hepatitis, with the development of direct-acting antiviral agents (DAAs) to treat hepatitis C virus infection.1 Despite this breakthrough, the incidence of liver disease continues to rise, driven in particular by the increase in obesity-related fatty-liver disease and the consequences of excess alcohol consumption.2 Patients with CLD are at an increased risk of developing progressive liver fibrosis, cirrhosis, and liver failure.

Source: LANCET - January 12, 2018 Category: General Medicine Authors: Daniel A Patten, Shishir Shetty Tags: Comment Source Type: research